Status:

COMPLETED

Sympathetic-parasympathetic Ratio of Our Gaze

Lead Sponsor:

Kecioren Education and Training Hospital

Conditions:

Autonomic Nervous System Diseases

Eligibility:

All Genders

Brief Summary

ABSTRACT BACKGROUND The existence of the retinohypothalamic pathway suggests that light may influence autonomic outflow activity. The objective of this study was to examine the correlation between the...

Detailed Description

INTRODUCTION The iris is the only tissue in which simultaneous interactions among smooth muscles stimulated by sympathetic and parasympathetic nerves can be observed with the naked eye. The iris conta...

Eligibility Criteria

Inclusion

  • We enrolled apparently healthy subjects

Exclusion

  • History of diabetes mellitus, hypertension, coronary artery disease, heart failure, cigarette smoking, eye disease, psychological illness, or drug therapy affecting the ANS

Key Trial Info

Start Date :

March 10 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 5 2017

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT03322904

Start Date

March 10 2016

End Date

March 5 2017

Last Update

October 26 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Şahbender Koç

Ankara, Turkey (Türkiye), 06400

Sympathetic-parasympathetic Ratio of Our Gaze | DecenTrialz